{
    "clinical_study": {
        "@rank": "85689", 
        "arm_group": [
            {
                "arm_group_label": "Randomized/Control", 
                "arm_group_type": "No Intervention", 
                "description": "7 patients randomized to deferred treatment/control cohort at the 3 sub-study control sites = 21"
            }, 
            {
                "arm_group_label": "Non-Randomized/Treatment", 
                "arm_group_type": "Experimental", 
                "description": "Patients are non-randomized and if meet inclusion criteria receive the implantation of the PresVIEW device"
            }
        ], 
        "brief_summary": {
            "textblock": "Study to determine the effectiveness of the PresVIEW Scleral Implant to improve near vision\n      in patients who require reading glasses"
        }, 
        "brief_title": "Trial of the PresView Implant for the Improvement of Near Vision in Presbyopic Patients", 
        "condition": "Presbyopia", 
        "condition_browse": {
            "mesh_term": "Presbyopia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 45 or older at commencement of study\n\n          -  Best Corrected Distance Visual Acuity of .80 (20/25) or better\n\n          -  Patients must be alert, mentally competent, and able to comply with clinical study\n             requirements\n\n        Exclusion Criteria:\n\n          -  Any previous eye surgeries including cataract, LASIK (laser in situ keratomileusis),\n             or eye muscle surgery\n\n          -  Any chronic systemic diseases such as diabetes, heart disease, Lupus, etc.\n\n          -  Any eye diseases such as eye inflammation, infection, cataract, or retinal diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT01910207", 
            "nct_id": "NCT01933750", 
            "org_study_id": "EU-001"
        }, 
        "intervention": {
            "arm_group_label": "Non-Randomized/Treatment", 
            "intervention_name": "PresVIEW Device Implantation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Presbyopia", 
            "Reading Glasses", 
            "Near Vision"
        ], 
        "lastchanged_date": "August 30, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Clinique de la Vision"
                }, 
                "investigator": {
                    "last_name": "Dominique Pietrini, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt am Main", 
                        "country": "Germany"
                    }, 
                    "name": "Goethe - University Department of Ophthalmology"
                }, 
                "investigator": {
                    "last_name": "Thomas Kohnen, MD, PhD, FEBO", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mainz", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum der Johannes-Gutenberg-Universitat"
                }, 
                "investigator": {
                    "last_name": "Urs Bossmerbaumer, Dr. Med.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Area Oftalmologica Avanzada"
                }, 
                "investigator": {
                    "last_name": "Carlos Verges, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Midland Eye"
                }, 
                "investigator": {
                    "last_name": "Sunil Shah, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Multicenter, Controlled Clinical Study of the PresVIEW Scleral Implant for the Improvement of Near Visual Acuity in Presbyopic Patients", 
        "overall_contact": {
            "email": "sburke@refocus-group.com", 
            "last_name": "Selene Burke, O.D.", 
            "phone": "214-368-0200"
        }, 
        "overall_contact_backup": {
            "email": "jschmitt@refocus-group.com", 
            "last_name": "Jason Schmitt, O.D.", 
            "phone": "214-368-0200"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom:  National Health Service, Health Research Authority", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of the distance Corrected Near Visual Acuity at 40 centimeters compared to baseline measurement.  A minimum of 75% of patients with a bilateral post-operative Distance Corrected Near Visual Acuity of .5 (20/40) or better at 12 months", 
            "measure": "Near Visual Acuity", 
            "safety_issue": "No", 
            "time_frame": "12 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01933750"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The percent of patients with a bilateral post-operative uncorrected near visual acuity (UCNVA) at 40 centimeters of .5 (20/40) or better at 12 months", 
                "measure": "Uncorrected Near Visual Acuity", 
                "safety_issue": "No", 
                "time_frame": "12 Months"
            }, 
            {
                "description": "Several indicators of safety are monitored including but not limited to Best Corrected Distance Visual Acuity, Intra-ocular Pressure, and Chronic Inflammation.", 
                "measure": "Presence of Significant Safety Events", 
                "safety_issue": "Yes", 
                "time_frame": "24 months"
            }
        ], 
        "source": "Refocus Ocular Europe, B.V.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Refocus Ocular Europe, B.V.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}